![](/img/cover-not-exists.png)
SUN-LB75 The Anti-Tumor Activity of the Selective Ret Inhibitor Selpercatinib (LOXO-292) in Medullary Thyroid Cancer Is Independent of the Specific RET Mutation
Cabanillas, Maria E, Wirth, Lori J, Sherman, Eric J, Drilon, Alexander, Solomon, Benjamin, Robinson, Bruce G, Lorch, Jochen H, McCoach, Caroline, Patel, Jyoti, Leboulleux, Sophie, Worden, Francis, OwoVolume:
4
Journal:
Journal of the Endocrine Society
DOI:
10.1210/JENDSO/BVAA046.2223
Date:
May, 2020
File:
PDF, 93 KB
2020